MRN joins The Avoca Group Quality Consortium as the first and only CTSO specializing in decentralized trials
MRN are excited and proud to announce that we have joined The Avoca Group Quality Consortium (AQC).
Founded in 2011, this collaborative is comprised of 120+ pharma, biotech, CRO and clinical service companies with the shared objective of elevating clinical trial quality and bringing key stakeholders in the clinical trials process into greater alignment.
MRN joins the consortium as the first clinical trial support organization specializing in decentralized/community-based clinical trials.
MRN are leaders in the execution of community-based clinical research, having delivered over 40,000 remote visits around the globe, enabling patients to be seen when and where they want, while helping our customers to improve patient enrolment and retention. We look forward to working with our new colleagues to help drive continual quality improvements across our industry